Grifols, S.A. (BME:GRF)
Spain
· Delayed Price · Currency is EUR 9.31
-0.17 (-1.81%)
Feb 21, 2025, 5:35 PM CET
Grifols Revenue
Grifols had revenue of 1.79B EUR in the quarter ending September 30, 2024, with 12.24% growth. This brings the company's revenue in the last twelve months to 7.01B, up 7.21% year-over-year. In the year 2023, Grifols had annual revenue of 6.59B with 8.71% growth.
Revenue (ttm)
7.01B
Revenue Growth
+7.21%
P/S Ratio
0.90
Revenue / Employee
304.61K
Employees
23,744
Market Cap
5.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6.59B | 528.01M | 8.71% |
| Dec 31, 2022 | 6.06B | 1.13B | 22.92% |
| Dec 31, 2021 | 4.93B | -406.92M | -7.62% |
| Dec 31, 2020 | 5.34B | 241.35M | 4.73% |
| Dec 31, 2019 | 5.10B | 611.97M | 13.64% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Laboratorios Farmaceuticos Rovi | 799.25M |
| Almirall | 953.49M |
| Pharma Mar | 167.00M |
| Faes Farma | 504.04M |
| Clínica Baviera | 252.47M |
| Atrys Health | 211.11M |
| Laboratorio Reig Jofre | 333.69M |
| Prim, S.A. | 227.57M |
Grifols News
- 7 days ago - Permian Investment Partners, LP Increases Stake in Grifols SA - GuruFocus
- 16 days ago - Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition - GlobeNewsWire
- 4 weeks ago - Grifols falls as Spanish regulator mulls sanctions against directors - Seeking Alpha
- 5 weeks ago - Grifols SA (GRFS) Partners with Michael J. Fox Foundation to Advance Parkinson's Disease Research - GuruFocus
- 5 weeks ago - Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease - GlobeNewsWire
- 5 weeks ago - Mason Capital complains about Grifols' transparency to Spanish regulator - Reuters
- 5 weeks ago - Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols - Business Wire
- 2 months ago - Short Seller Gotham Asks Judge to Toss Grifols Defamation Suit - BNN Bloomberg